Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Village Farms International, Inc. announced a succession plan for Chief Financial Officer Stephen Ruffini, who after 17 years will transition from CFO but remain with the company to lead mergers and acquisitions initiatives. The company will conduct a formal search for a permanent CFO replacement. The move reflects Village Farms' focus on growth th…
Plug Power Inc. announced that newly appointed CEO Jose Luis Crespo will host a Reddit AMA on April 16, 2026. The session will cover the company’s strategy, operational goals, hydrogen production facilities in the U.S., expansion of electrolyzer business globally, and Plug Power’s role in advancing the hydrogen economy. The AMA aims to engage inves…
BioCryst Pharmaceuticals announced inducement grants consisting of stock options and restricted stock units to 12 newly hired employees, as permitted under Nasdaq Listing Rule 5635(c)(4). The grants aim to attract talent by providing equity incentives with a four-year vesting schedule and ten-year option term at the closing price on the grant date.
Alta Equipment Group Inc., a leading North American equipment dealership platform, announced a quarterly dividend of $625 per Series A preferred share, payable on April 30, 2026. The dividend reflects the company's commitment to returning value to preferred shareholders while maintaining its extensive branch network across multiple U.S. states and …
Figure Technology Solutions announced preliminary operating results for March and Q1 2026, showing substantial increases in consumer loan marketplace volume, $YLDS in circulation, and activity across its Democratized Prime platform. The company continues to expand its blockchain-native capital marketplace and solidify its position as a market leade…
MiNK Therapeutics, a clinical-stage biopharmaceutical company, announced the upcoming presentation of Phase II clinical trial data evaluating their allogeneic invariant natural killer T cell therapy, agenT-797, combined with botensilimab and balstilimab in PD-1 refractory gastroesophageal cancer. The study, conducted at Memorial Sloan Kettering Can…
Kura Oncology announced inducement awards consisting of nonstatutory stock options to six new employees under its 2023 Inducement Option Plan, approved by the Compensation Committee in line with Nasdaq Listing Rule 5635(c)(4). The options grant a total of 153,750 shares at an exercise price of $8.34 per share, vesting over four years.
Lotus Technology Inc. has showcased two premier Emira models, including the new Racing Line Edition, at the 2026 New York International Auto Show. The Racing Line Edition emphasizes the brand's heritage with track-inspired design and performance enhancements, reinforcing Lotus's commitment to craftsmanship and luxury driving experiences.
MBX Biosciences, a clinical-stage biopharmaceutical company focused on precision peptide therapies for endocrine and metabolic disorders, announced an inducement grant of non-qualified stock options totaling 130,000 shares to Karen Basbaum upon her appointment as Chief Business Officer. The options have an exercise price of $32.29 per share, a 10-y…
Taysha Gene Therapies announced that it granted restricted stock units and stock options totaling 392,400 shares to four new employees as inducements for their employment. These equity awards are subject to vesting schedules and comply with Nasdaq Listing Rule 5635(c)(4). The company focuses on developing AAV-based gene therapies for severe monogen…
Bicara Therapeutics, a clinical-stage biopharmaceutical company focused on bifunctional therapies for solid tumors, announced an inducement grant of stock options to a new employee. The grant, approved under Nasdaq listing rules, includes options to purchase 44,175 shares at the closing price of $20.50 per share, vesting over time with continued em…
Rhythm Pharmaceuticals announced a change to its board of directors with the addition of Kim Popovits, an experienced biotech leader, and the departure of longtime director Ed Mathers. The company highlighted Popovits' expertise to support its ongoing growth and commercialization efforts, particularly for its rare disease treatments.
HII's Newport News Shipbuilding division has successfully completed post-shakedown availability work on the USS New Jersey (SSN 796), a Virginia-class fast attack submarine, and redelivered it to the U.S. Navy. The maintenance period included combat systems and electronics upgrades, ensuring enhanced operational readiness and reinforcing the nation…
Navient will release its first quarter 2026 financial results on April 29, hosting an audio webcast and providing presentation materials to investors. The results will also be filed with the SEC and accessible via the company's investor website.
First Bank, a New Jersey state-chartered bank with operations from New York to Florida, announced its first quarter 2026 earnings release on April 27, 2026, followed by a conference call on April 28, 2026. Executives will discuss the bank's financial and operating performance, providing investors with insights into recent results and outlook.
HII's Ingalls Shipbuilding hosted former U.S. Senator Sam Nunn and family to observe the construction progress of the USS Sam Nunn (DDG 133), a Flight III Arleigh Burke-class destroyer named in his honor. The visit highlights ongoing advancements in this key naval shipbuilding project, which incorporates modern defense technologies to enhance U.S. …
Ponce Bank, a minority-led community bank subsidiary of Ponce Financial Group, Inc., was ranked #40 among the Top 50 Best-Performing U.S. Community Banks in the $3 billion to $10 billion asset category by S&P Global Market Intelligence, highlighting its strong financial performance and commitment to community development.
Airgain Inc. President and CEO Suen Jacob sold 1,000 shares on April 1, 2026, under a Rule 10b5-1 plan, netting $5,510. The company reported Q4 2025 results that missed analyst expectations while disclosing new commercial wins and a strategic partnership aimed at expanding 4G and 5G coverage. Shares are trading near their assessed Fair Value and th…
Australia, which implemented the world’s first ban on under-16s using popular social media apps in December, has moved from a cooperative posture to heightened enforcement after a government regulator found substantial noncompliance. With at least eight other countries expressing interest in similar measures and recent U.S. court rulings against ma…
A coalition of over 100 international law scholars in the United States has accused U.S. actions and statements related to strikes on Iran of raising serious concerns about breaches of international human rights and humanitarian law, including potential war crimes. The letter cites explicit comments by senior U.S. officials and specific strikes tha…
Ionis Pharmaceuticals director Joseph Klein III executed sales of 22,321 shares on April 1, 2026, totaling about $1.69 million, while also exercising options that converted to 22,321 shares with an aggregate value of $880,706. The company simultaneously disclosed new wholesale pricing for Tryngolza and multiple firms adjusted or reaffirmed analyst …
Rubrik director John Wendell Thompson sold 13,500 Class A shares on April 1, 2026, for about $660,331 under a Rule 10b5-1 trading plan, including the conversion of 11,000 Class B shares to Class A. The company's stock has fallen 39% over six months even as Rubrik reported quarterly results and an outlook that topped FactSet consensus and launched s…
Shannon L. Devers, Executive Vice President and Chief Human Resources Officer at Ionis Pharmaceuticals (IONS), disposed of 6,193 shares on April 2, 2026 under a Rule 10b5-1 plan, netting $458,613 at a weighted average price of $74.0535. The transaction coincides with a new wholesale acquisition cost for Tryngolza that exceeds earlier guidance and h…
Reddit Chief Executive Officer Steve Huffman sold 14,697 shares of Class A common stock on March 31, 2026, realizing roughly $2.39 million in proceeds. The sales followed an option exercise that added 18,000 shares at $25.29 per share. The transactions took place under a Rule 10b5-1 plan adopted in May 2025. Reddit recently reported strong fourth-q…
John W. Kozarich, a director of Ligand Pharmaceuticals Inc (LGND), sold 467 shares on April 1, 2026, for roughly $94,440 under a pre-arranged trading plan. The transaction comes amid strong quarterly results for Ligand and mixed valuation signals from market analytics and analysts alike. Following the trades Kozarich holds 42,253 shares.
